MODV
ModivCare Inc.
NASDAQ · Healthcare · Medical - Care Facilities · US
$0.43
+0.00%Income statement
| Metric | TTM | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.7B | 2.8B | 2.8B | 2.5B | 2.0B |
| Cost of Revenue | 1.2B | 2.4B | 2.3B | 2.0B | 1.6B |
| Gross Profit | 202.8M | 420.4M | 447.0M | 472.3M | 412.6M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 307.8M | 298.4M | 304.6M | 322.2M | 271.3M |
| General & Admin Expense | 307.8M | 298.4M | 304.6M | 322.2M | 271.3M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 1.5B | 214.8M | 282.3M | 93.1M | 51.6M |
| Total Operating Expenses | 1.8B | 513.2M | 586.9M | 415.2M | 322.8M |
| Cost and Expenses | 1.4B | 2.9B | 2.9B | 2.4B | 1.9B |
| Operating Income (EBIT) | (12.2M) | (92.8M) | (139.9M) | 57.1M | 89.8M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 117.3M | 94.1M | 69.1M | 62.0M | 49.1M |
| Net Interest Income | (65.8M) | (94.1M) | (69.1M) | (62.0M) | (49.1M) |
| Other Non-Op Income/Expense | (141.5M) | (114.0M) | (68.8M) | (62.0M) | (49.1M) |
| Non-Operating Income (excl Interest) | — | 11.8M | — | — | — |
| EBT (Pre-Tax Income) | (459.4M) | (206.8M) | (208.8M) | (4.9M) | 40.7M |
| Income Tax Expense | (6.9M) | (5.5M) | (4.3M) | (3.0M) | 8.7M |
| Bottom Line | |||||
| Net Income | (450.7M) | (201.3M) | (204.5M) | (1.8M) | 32.0M |
| Earnings from Cont. Ops | (147.0M) | (201.3M) | (204.5M) | (31.8M) | (6.6M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (147.0M) | (201.3M) | (204.5M) | (31.8M) | (6.6M) |
| Per Share | |||||
| Basic EPS | ($31.40) | ($14.14) | ($14.43) | ($0.13) | $2.27 |
| Diluted EPS | ($31.40) | ($14.14) | ($14.43) | ($0.13) | $2.27 |
| Revenue Per Share | $186.98 | $195.76 | $194.10 | $178.10 | $142.09 |
| Shares | |||||
| Basic Shares Outstanding | 14.4M | 14.2M | 14.2M | 14.1M | 14.1M |
| Diluted Shares Outstanding | 14.4M | 14.2M | 14.2M | 14.1M | 14.1M |
| Profitability Metrics | |||||
| EBITDA | (235.5M) | 4.9M | (35.7M) | 157.5M | 146.8M |
| D&A | 96.9M | 109.5M | 104.3M | 112.1M | 68.3M |
| EBIT | (174.0K) | (104.6M) | (139.9M) | 57.1M | 89.4M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2025